OBJECTIVES: Equisetum arvense preparations have long been used to promote bone healing. The aim of this work was to evaluate osteogenic and antibacterial effects of E. arvense hydromethanolic extracts. MATERIALS AND METHODS: Dried aerial components of E. arvense were extracted using a mixture of methanol:water (1:1), for 26 days, yielding three extracts that were tested (10-1000 μg/ml) in human osteoblastic cells: E1, E2 and EM (a mixture of E1 and E2, 1:1). Cell cultures, performed on cell culture plates or over hydroxyapatite (HA) substrates, were assessed for osteoblastic markers. In addition, effects of the extracts on Staphylococcus aureus were addressed. RESULTS: Solution E1 caused increased viability/proliferation and ALP activity at 50-500 μg/ml, and deleterious effects at levels ≥1000 μg/ml. E2 inhibited cell proliferation at levels ≥500 μg/ml. EM presented a profile between those observed with E1 and E2. In addition, E1, E2 and EM, 10-1000 μg/ml, inhibited expansion of S. aureus. Furthermore, E1, tested in HA substrates colonized with osteoblastic cells, causing increase in cell population growth (10-100 μg/ml). E1 also exhibited antibacterial activity against S. aureus cultured over HA. CONCLUSIONS: Results showed that E. arvense extracts elicited inductive effects on human osteoblasts while inhibiting activity of S. aureus, suggesting a potentially interesting profile regarding bone regeneration strategies.
OBJECTIVES:Equisetum arvense preparations have long been used to promote bone healing. The aim of this work was to evaluate osteogenic and antibacterial effects of E. arvense hydromethanolic extracts. MATERIALS AND METHODS: Dried aerial components of E. arvense were extracted using a mixture of methanol:water (1:1), for 26 days, yielding three extracts that were tested (10-1000 μg/ml) in human osteoblastic cells: E1, E2 and EM (a mixture of E1 and E2, 1:1). Cell cultures, performed on cell culture plates or over hydroxyapatite (HA) substrates, were assessed for osteoblastic markers. In addition, effects of the extracts on Staphylococcus aureus were addressed. RESULTS: Solution E1 caused increased viability/proliferation and ALP activity at 50-500 μg/ml, and deleterious effects at levels ≥1000 μg/ml. E2 inhibited cell proliferation at levels ≥500 μg/ml. EM presented a profile between those observed with E1 and E2. In addition, E1, E2 and EM, 10-1000 μg/ml, inhibited expansion of S. aureus. Furthermore, E1, tested in HA substrates colonized with osteoblastic cells, causing increase in cell population growth (10-100 μg/ml). E1 also exhibited antibacterial activity against S. aureus cultured over HA. CONCLUSIONS: Results showed that E. arvense extracts elicited inductive effects on human osteoblasts while inhibiting activity of S. aureus, suggesting a potentially interesting profile regarding bone regeneration strategies.
Authors: Sophie E Putnam; Andy M Scutt; Katrina Bicknell; Caroline M Priestley; Elizabeth M Williamson Journal: Phytother Res Date: 2007-02 Impact factor: 5.878
Authors: Nadia Musco; Giuseppe Vassalotti; Vincenzo Mastellone; Laura Cortese; Giorgia Della Rocca; Maria Luce Molinari; Serena Calabrò; Raffaella Tudisco; Monica Isabella Cutrignelli; Pietro Lombardi Journal: Vet Med Sci Date: 2019-07-17
Authors: Jonatas Rafael de Oliveira; Vinicius Carlos de Castro; Polyana das Graças Figueiredo Vilela; Samira Esteves Afonso Camargo; Cláudio Antonio Talge Carvalho; Antonio Olavo Cardoso Jorge; Luciane Dias de Oliveira Journal: BMC Complement Altern Med Date: 2013-08-15 Impact factor: 3.659
Authors: Carsten Gründemann; Karin Lengen; Barbara Sauer; Manuel Garcia-Käufer; Martin Zehl; Roman Huber Journal: BMC Complement Altern Med Date: 2014-08-04 Impact factor: 3.659